September 2024 - Page 11 of 13

FridaySep 06, 2024 10:30 am

SuperCom Ltd. (NASDAQ: SPCB) Reports Revenue Growth with Offender Supervision Contract in Baltimore

SuperCom Ltd., a secure solutions provider for the e-Government, IoT and Cybersecurity sectors, capitalizes on its proprietary technology suite and experienced 24/7 services to help government clients track and identify individuals under legal supervision The Israel-based company is focused on public safety through the monitoring of parolees and probation orders, domestic violence suspects and substance abuse rehabilitation patients SuperCom has reported a number of new contracts in the United States and Europe this year, helping the company to recognize record gross profit growth and a move into positive territory for its bottom line The offender-tracking industry provides value to society…

FridaySep 06, 2024 9:55 am

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Shares Letter from Outgoing CEO

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, provided a strategic letter from outgoing CEO Chris Bunka updating all stakeholders. In the strategic update, Bunka discussed Lexaria’s performance in the capital markets; the company’s Phase 1b DehydraTECH-CBD hypertension trial and Australian-registered Phase 1b DehydraTECH-GLP-1 diabetes and weight-loss study; ongoing R&D; and his reason for stepping aside from his role as CEO. “It is because of the combination of events that include our successful money-raising, our R&D success, our new relationship with one pharmaceutical company and continued pursuit of others, and our confidence in our strategic direction…

FridaySep 06, 2024 9:45 am

Clene Inc. (NASDAQ: CLNN) Seeks to Transform Neurodegenerative Disorder Treatments, with Rise in Prevalence and Associated Markets

With a focus on improving mitochondrial health, CNM-Au8® stands out among other therapies by targeting the nicotinamide adenine dinucleotide pathway to restore and protect neurological function. Nearly 2 million Americans are affected by amyotrophic lateral sclerosis (“ALS”), multiple sclerosis (“MS”) or Parkinson’s disease. The global therapeutics markets for neurogenerative diseases are projected to grow substantially, driven by the growing prevalence of these conditions, rising geriatric population and the emergence of new therapies. Clene is preparing Phase 3 trials of CNM-Au8 in MS and ALS. Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal…

FridaySep 06, 2024 9:00 am

Amid Record Market Highs, 2,500+ Investors Seek Timely Guidance in Toronto

More Than 60 Top Financial Experts Converging on the Metro Toronto Convention Centre North from Sept. 13-14 for MoneyShow’s “Outlook 2024-2025: Politics, Policy, & Profits” Conference Canadian investors have had several reasons to celebrate in 2024. They include new stock market highs at home and abroad...strength in select commodities, including a move to record highs in gold...and interest rate cuts now underway domestically and globally. Yet many questions remain. How will potential political regime shifts in Canada and the U.S. over the coming year impact their portfolios? What will changes in tax law and government programs mean for stocks and…

ThursdaySep 05, 2024 11:15 am

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Appoints Medical Device and Pharmaceutical Industries Veteran as New CEO

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced the appointment of Richard Christopher as the new CEO, effective August 31, 2024. Mr. Christopher is a recognized industry veteran with over three decades of experience in the medical device and pharmaceutical industries. He has domestic and international experience in leadership, operations, acquisitions/licensing, business development, strategic planning and capital markets. Mr. Christopher takes over from outgoing CEO, Chris Bunka, who has stepped aside from the role. Mr. Bunka remains as the Chairman of the Board of Directors and has been appointed Executive Strategic Advisor to the…

ThursdaySep 05, 2024 10:49 am

QualityStocksNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

Annovis Bio (NYSE: ANVS), a late-stage, drug-platform company developing novel therapies for neurodegenerative diseases such as Alzheimer’s (“AD”) and Parkinson’s disease (“PD”), today announced participation at the H.C. Wainwright 26th Annual Global Investment Conference. The conference, held virtually and in person, is scheduled for September 9-11, 2024, at the Lotte New York Palace Hotel in New York City. According to the announcement, Maria L. Maccecchini, Ph.D., Founder, President, and CEO of Annovis Bio, will deliver a 30-minute company presentation on Tuesday, September 10, 2024, at 8 a.m. ET. Later that day, at 2 p.m. ET., Dr. Maccecchini will take part in…

ThursdaySep 05, 2024 10:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Yields “Extremely Interesting” Results for DehydraTECH(TM) Liraglutide in Ongoing Diabetes Animal Study

Lexaria, a global innovator in drug delivery platforms, has just announced its 4-week and 8-week blood glucose results from its WEIGHT-A24-1 animal study Two formulations from the study posted outstanding performance, with each utilizing the company’s patented DehydraTECH(TM) technology DehydraTECH-liraglutide (Group H) and two DehydraTECH-CBD formulations (Groups A & B) posted blood sugar level reductions of 2.50%, 1.90%, and 1.53%, respectively These results build on the positive results from Lexaria’s 2023 DIAB-A22-1 animal study, which showed a 16.7% blood sugar concentration increase relative to baseline by day 56 for the obese control group that got no treatment Lexaria Bioscience (NASDAQ:…

ThursdaySep 05, 2024 9:45 am

D-Wave Quantum Inc. (NYSE: QBTS) and NTT DOCOMO Leverage Quantum Optimization Technology to Boost Mobile Network Performance

A pilot project with Japan’s largest mobile service provider showed that the deployment of D-Wave’s annealing quantum computing solutions improved mobile network performance by 15%. D-Wave’s hybrid solver was able to process a task in just 40 seconds, compared to 27 hours with a general-purpose solver. The project demonstrated a significant reduction in signal congestion across base stations, which can potentially lead to more efficient transmission and cost savings. This collaboration marks an important step in applying and further integrating quantum computing in telecommunications. D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the…

ThursdaySep 05, 2024 9:00 am

Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF) Completes Perforation Program, Boosts Gas Production to 7.3 MMCF/d

SASB gas field is producing critical domestic supply of natural gas during Europe’s current energy crisis. With all perforations now complete, West Akcakoca-1 is producing 2.8 MMcf/d using a 28/64 choke to ensure its high pressure will not back out other wells. The next program phase aims to end this year with five development wells and one stratigraphic well, for a total of six producing wells. Trillion Energy International (CSE: TCF) (OTCQB: TRLEF), a company focused on oil and natural gas production for Europe and Türkiye, has perforated all remaining gas pay in the SASB wells and has provided an…

WednesdaySep 04, 2024 3:25 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Slated to Present at H.C. Wainwright 26th Annual Global Investment Conference

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be participating in the upcoming H.C. Wainwright 26th Annual Global Investment Conference. The event is slated for Sept. 9–11, 2024, in New York. According to the announcement, CEO John Climaco will present at the event; his presentation will be available as an on-demand video webcast beginning Sept. 9 at 7 a.m. ET. Climaco will also be available to participate in one-on-one meetings. To view the on-demand webcast, visit https://ibn.fm/gaP8o To view the full…

Site Search

Company Search

Month: September 2024